Detalhe da pesquisa
1.
Importance of recombinant human thyrotropin as an adjuvant in the radioiodine treatment of thyroid cancer.
Expert Rev Endocrinol Metab
; 12(4): 261-267, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058883
2.
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?
Endocrine
; 56(1): 129-137, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230768
3.
Severe Hypothyroidism due to the Loss of Therapeutic Efficacy of l-Thyroxine in a Patient with Esophageal Complication Associated with Systemic Sclerosis.
Front Endocrinol (Lausanne)
; 8: 241, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28979239
4.
Spindle epithelial tumor with thymus-like differentiation (SETTLE): clinical-pathological features, differential pathological diagnosis and therapy.
Endocrine
; 51(3): 402-12, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26289127
5.
Recombinant Human Thyrotropin Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients with Differentiated Thyroid Cancer.
Thyroid
; 26(11): 1528-1534, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27558484
6.
Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.
Thyroid
; 26(11): 1563-1572, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27604949
7.
Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation.
Endocrine
; 60(1): 193-196, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28702889
8.
Under the shadow of vesuvius: a risk for thyroid cancer?
Thyroid
; 22(12): 1296-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23083444